ContraceptionSafety and efficacy of a single-rod etonogestrel implant (Implanon): results from 11 international clinical trials
Under an Elsevier user license
open archive
Key Words
Contraceptive implant
etonogestrel
menstruation
desogestrel
levonorgestrel
Cited by (0)
Supported by Organon.
Dr. Darney has received research funding from Organon and has served as an advisor to Organon. Dr. Patel has served on the Speakers' Bureau for Organon. Dr. Kaunitz has received research funding from Barr, Bayer, Organon, and Warner-Chilcott and has served as a speaker and/or consultant for the American College of Obstetricians and Gynecologists, Barr, Bayer, Johnson and Johnson, Organon, and Warner-Chilcott. Dr. Rosen has nothing to disclose. D. Shapiro has nothing to disclose.
Copyright © 2009 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.